With more than 90% of the goal reached for Campaign for Our Future, NHF recently launched the second phase of the fundraising campaign. Phase II--Campaign for Our Future, Research is Our Future--has a specific focus on research, because research is our future.
For more than 60 years, NHF has been a leader in the field of scientific research for bleeding disorders and remains the largest nongovernmental organization committed to this type of science. Currently, there is no dedicated source of funding for the critical research that must be done to continue improving treatments and one day find a cure.
That is why we count on individuals like you. In fact, most every major medical advancement in the treatment and care of people with bleeding disorders has been made possible through funding from individuals.
To learn more about Campaign for Our Future or to make a contribution, please click here. All donations made by Thursday, December 31, 2009, are tax deductible for 2009.
The Visionary Corporate Partner and Lead Benefactor for Campaign for Our Future is Novo Nordisk. Other major sponsors include: Baxter, Principal Corporate Partner; Bayer, CSL Behring and Pfizer, Major Corporate Partners; and Grifols, Corporate Partner.